DMCC Speciality Chemicals Ltd Q4 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/i3h8cdtd5sthvbgazc7yq95n.pdf

Key Takeaways


Supply Chain Disruptions

Goculdas: "Sulfur continues to be in short supply, which has resulted in ever-increasing prices to all-time high levels."

Revenue & Margin Mechanics


The Specialty Identity Question


Balance Sheet & Working Capital

Goculdas: "Very much out of my control."

Market Structure & Competitive Dynamics


Guidance & Commitments

CommitmentSpecificsTimeline
Specialty pricing recoveryRecover margin lost from lag in passing on price increasesNext quarter
Non-boric acid demandDemand will not return until gas situation normalizesNo date (depends on gas)
Sulfur supply normalizationEven if straits open, supply chain takes a few months to normalize; will not bounce back to old levels even if fighting stops nowMonths after straits reopen
New specialty commercializationSome products under research to reach commercial stageFY27 or FY28
R&D spend increasePlans for increasing R&D visible in coming quartersComing quarters
Goculdas: "It's really my style not to give futuristic projections. I will continue that way. I know it may not satisfy all of you, but that's the way we have taken the company over the past few years."

Key Metrics

MetricQ4 FY26
Revenue₹177 cr, up from ₹150 cr in Q3 FY26
Full-year revenue₹582 cr, one of the highest top lines in the company
Working capital to salesLess than 2 months, within industry norms
Incremental working capital interest rate8.75% to 9%
Roha plant utilization~60% for ~15 days in March due to sulfur availability
Sulfur inventory~1,500 tons per location, 15–20 days maximum
Sulfuric acid capacity (Roha)~350 tons per day
Sulfuric acid capacity (Dahej)~350 tons per day
Boron business payment termsShifted from credit to advance payment with 90–120 day lead time for material
Global sulfur trade through Hormuz~50%
Sulfur pulled by Indonesia nickel smelter~0.3 crore tons
Historical R&D spendNo more than ₹2 cr annually
Target specialty chemicals share~60% of portfolio (currently lower due to sulfuric acid expansion and Europe decline)